PACS Group (NYSE:PACS) Stock Price Down 7.6% – Should You Sell?

PACS Group, Inc. (NYSE:PACS – Get Free Report)’s stock price traded down 7.6% on Thursday. The company traded as low as $43.24 and last traded at $42.7970. Approximately 142,318 shares were traded during trading, a decline of 84% from the average daily volume of 887,698 shares. The stock had previously closed at $46.30.

Analyst Ratings Changes

Several equities analysts have recently weighed in on PACS shares. UBS Group raised their price target on shares of PACS Group from $60.00 to $67.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Truist Financial reissued a “buy” rating and issued a $65.00 price objective (up from $62.00) on shares of PACS Group in a research report on Thursday, November 5th. Weiss Ratings upgraded shares of PACS Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, November 4th. Finally, Royal Bank Of Canada raised their target price on shares of PACS Group from $57.00 to $64.00 and gave the company an “outperform” rating in a research report on Monday, November 16th. Seven equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, PACS Group has an average rating of “Moderate Buy” and a consensus target price of $62.50.

Read Our Latest Research Report on PACS

PACS Group Trading Up 1.4%

The firm has a market cap of $6.92 billion, a price-to-earnings ratio of 24.65, a P/E/G ratio of 1.59 and a beta of -0.14. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.80 and a quick ratio of 0.80. The business has a 50-day moving average of $45.45 and a 200-day moving average of $40.65.

PACS Group (NYSE:PACS – Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.58 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.46 billion. PACS Group had a return on equity of 31.98% and a net margin of 4.87%. Research analysts anticipate that PACS Group, Inc. will post 2.05 EPS for the current year.

Insider Buying and Selling

In other news, COO Joshua Jergensen sold 40,000 shares of the stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $50.11, for a total value of $2,004,400.00. Following the completion of the sale, the chief operating officer owned 2,416,320 shares of the company’s stock, valued at approximately $121,081,795.20. This represents a 1.63% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark Hancock sold 186,696 shares of the firm’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.45, for a total transaction of $9,418,813.20. Following the completion of the transaction, the director directly owned 53,318,884 shares of the company’s stock, valued at $2,689,937,697.80. This represents a 0.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,395,000 shares of company stock worth $64,793,252. 70.10% of the stock is currently owned by company insiders.

Institutional Trading of PACS Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in PACS. Zacks Investment Management lifted its stake in PACS Group by 11.3% in the third quarter. Zacks Investment Management now owns 40,754 shares of the company’s stock valued at $1,693,000 after acquiring an additional 4,123 shares during the last quarter. Aquatic Capital Management LLC acquired a new position in shares of PACS Group during the 3rd quarter worth about $723,000. Cetera Investment Advisers increased its stake in shares of PACS Group by 57.1% during the 3rd quarter. Cetera Investment Advisers now owns 18,201 shares of the company’s stock worth $756,000 after purchasing an additional 6,619 shares during the last quarter. Caxton Associates LLP bought a new stake in shares of PACS Group in the 3rd quarter valued at about $289,000. Finally, Bleakley Financial Group LLC raised its holdings in shares of PACS Group by 46.7% in the 3rd quarter. Bleakley Financial Group LLC now owns 32,604 shares of the company’s stock valued at $1,355,000 after purchasing an additional 10,385 shares during the period.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.

Further Reading

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.